ArticleBritish journal of pharmacology2020

PO-322 exerts potent immunosuppressive effects in vitro and in vivo by selectively inhibiting SGK1 activity.

Yi Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.